Progenra, Inc. and Ono Pharmaceutical Co., Ltd. Enter into Research Collaboration

“We are pleased that Progenra’s unique UbiPro™ Drug Discovery Platform is gaining traction outside the US and that a major pharmaceutical company such as Ono has agreed to collaborate with Progenra on the ubiquitin and ubiquitin-like protein pathways,” said Tauseef Butt, President and CEO of Progenra. “Given Progenra’s accumulated knowledge and know-how in this space and Ono’s proven drug discovery record, we are confident of success.”